Literature DB >> 10953052

Functional differences between the amino-terminal domains of estrogen receptors alpha and beta.

F Delaunay1, K Pettersson, M Tujague, J A Gustafsson.   

Abstract

Human estrogen receptors alpha (ERalpha) and beta (ERbeta) are ligand-inducible transcription factors that are highly homologous in their central DNA-binding and carboxyl-terminal ligand-binding domains. In contrast, there is very little conservation between ERalpha and ERbeta in the amino-terminal domain. Using different human cell lines, we show that wild-type ERbeta transcriptional activity is lower or similar to that of ERalpha, depending on the cell type. Deletion of the amino-terminal domain in both ER subtypes resulted in no or a lower decrease of transcriptional activity of ERbeta compared with ERalpha, suggesting that the ERbeta amino-terminal domain contains a weaker transcriptional activation function-1. Using ERalpha and ERbeta deletion mutants, we showed that the amino-terminal transcriptional activity of ERbeta maps to amino acids 1-31. Interestingly, this domain contains a six amino-acid motif (amino acids 5-10 in human ERbeta) that is part of the ERalpha-activation function-1 region (amino acids 49-54 in human ERalpha) and highly conserved among all mammalian ERalpha amino-terminal domains. Despite this similarity between the two ER subtypes, no autonomous and ligand-independent activity of the ERbeta-amino-terminal domain was observed in yeast and mammalian cells in contrast to ERalpha. This study provides a molecular basis for the difference in transcriptional activity between ERalpha and ERbeta and establishes that ERbeta contains a structurally and functionally restricted amino-terminal transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953052     DOI: 10.1124/mol.58.3.584

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  48 in total

1.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

Review 2.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

3.  Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.

Authors:  Jason Matthews; Björn Wihlén; Jane Thomsen; Jan-Ake Gustafsson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 4.  The role of estrogens and estrogen receptors in normal prostate growth and disease.

Authors:  Gail S Prins; Kenneth S Korach
Journal:  Steroids       Date:  2007-11-12       Impact factor: 2.668

Review 5.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

Review 6.  Interplay of estrogen receptors and FOXA factors in the liver cancer.

Authors:  Yongbing Zhao; Zhaoyu Li
Journal:  Mol Cell Endocrinol       Date:  2015-02-04       Impact factor: 4.102

7.  The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin.

Authors:  Joëlle Rüegg; Elin Swedenborg; David Wahlström; Aurelie Escande; Patrick Balaguer; Katarina Pettersson; Ingemar Pongratz
Journal:  Mol Endocrinol       Date:  2007-11-08

8.  p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.

Authors:  Asmaà Fritah; Cécile Saucier; Jan Mester; Gérard Redeuilh; Michèle Sabbah
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes.

Authors:  Heather A Molenda-Figueira; Suzanne D Murphy; Katherine L Shea; Nora K Siegal; Yingxin Zhao; Joseph G Chadwick; Larry A Denner; Marc J Tetel
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

Review 10.  Probing the link between oestrogen receptors and oesophageal cancer.

Authors:  Farhan Rashid; Raheela N Khan; Syed Y Iftikhar
Journal:  World J Surg Oncol       Date:  2010-02-10       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.